Elizabeth Sattely's group maps and reconstitutes plant metabolic pathways, builds heterologous production and single-cell screening platforms, and tunes root-microbiome chemistry to enable sustainable biomanufacturing of plant-derived therapeutics and improved nutrition and disease resilience.